Tango Therapeutics Inc (TNGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Sales | 29,241 | 27,312 | 26,047 | 22,341 | 18,676 |
| Cost of Goods | 13,929 | 13,068 | 12,653 | 10,329 | 8,166 |
| Gross Profit | 15,312 | 14,244 | 13,394 | 12,012 | 10,510 |
| Operating Expenses | 15,038 | 14,685 | 13,008 | 11,633 | 10,380 |
| Operating Income | 1,203 | -373 | 1,039 | 708 | 296 |
| Interest Expense | 184 | 1,427 | 777 | 659 | 407 |
| Other Income | 24 | 33 | -1,472 | -536 | -315 |
| Pre-tax Income | 1,043 | -1,767 | -1,210 | -487 | -426 |
| Income Tax | 140 | 88 | 180 | 126 | 113 |
| Net Income Continuous | 903 | -1,855 | -1,390 | -613 | -539 |
| Net Income | $903 | $-1,855 | $-1,390 | $-613 | $-539 |
| EPS Basic Total Ops | 0.60 | -0.10 | -0.48 | -0.33 | -0.33 |
| EPS Basic Continuous Ops | 0.32 | -0.08 | -0.29 | -0.13 | -0.12 |
| EPS Diluted Total Ops | 0.60 | -0.10 | -0.48 | -0.33 | -0.33 |
| EPS Diluted Continuous Ops | 0.32 | -0.08 | -0.29 | -0.13 | -0.12 |
| EBITDA(a) | $2,559 | $1,698 | $2,387 | $1,915 | $1,204 |